GCP
SXTC icon

GSA Capital Partners’s China SXT Pharmaceuticals SXTC Stock Holding History

GSA Capital Partners’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$9K – 2020
2024
Q3 		$9K Buy
+10
New +$10.8K ﹤0.01% 1537

Other funds holding SXTC

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSA Capital Partners's SXTC Position: Q4 2024 in Review

GSA Capital Partners sold out of China SXT Pharmaceuticals (SXTC) in Q4 2024, closing a stake of 10 shares — an estimated $9K sold.

GSA Capital Partners first reported a position in SXTC in Q3 2024 and held it in 1 quarter. The position peaked at $9K in Q3 2024. 1 fund tracked by Wall St. Rank holds SXTC as of Q4 2024.

  • GSA Capital Partners reported no remaining China SXT Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 10 China SXT Pharmaceuticals shares in Q4 2024, an estimated $9K.
  • GSA Capital Partners first reported a position in China SXT Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • GSA Capital Partners's China SXT Pharmaceuticals position peaked at $9K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.